DR. ERIC C LEE M.D. NPI 1760481808

NPI Information

  • NPI: 1760481808
  • Provider Name: DR. ERIC C LEE, M.D.
  • Classification: Specialist - 174400000X
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1238 E ARROW HWY
    UPLAND, CA
    ZIP 91786
  • Phone: (909) 982-0099

Map and Directions

Get Directions

NPI Details

DR. Eric C Lee, M.D. is a specialist in Upland, CA with 29 years of experience. The provider is an individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree. DR. Eric C Lee, M.D. NPI is 1760481808. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Graduation Year:1997

The provider's business location address is:

1238 E ARROW HWY
UPLAND, CA
ZIP 91786-951
Phone: (909) 982-0099
Fax: (909) 931-0402

The NPI 1760481808 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Uric acid level, blood (HCPCS:84550)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Measurement of substance using immunoassay technique (HCPCS:83520)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody (HCPCS:86769)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • Rheumatoid factor level (HCPCS:86431)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Measurement of dna antibody, single stranded (HCPCS:86226)
  • Immune complex measurement (HCPCS:86332)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • X-ray of wrist, minimum of 3 views (HCPCS:73110)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Vitamin d-3 level (HCPCS:82306)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • X-ray of knee, 3 views (HCPCS:73562)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • X-ray of joint between lower spine and hip bone, 3 or more views (HCPCS:72202)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
  • X-ray of chest, 2 views (HCPCS:71046)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)

The enumeration date for this NPI number is 7/20/2005 and was last updated on 9/22/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialistA67823CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1ZZZ00883ZMEDICARE ID-TYPE UNSPECIFIEDCALIFORNIA
2H56234MEDICARE UPINCALIFORNIA
3GR0091870MEDICAIDCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.